Individual level S. mansoni infection data obtained from individuals residing in a fishing village in the Lake Victoria region, Uganda, Musoli. Data include human host age; baseline S. mansoni egg counts, 9-week post-treatment Kato Katz S. mansoni egg counts (eggs/gram feces); 2-year post-treatment Kato Katz S. mansoni egg counts (epg), and post-treatment IgE-TAL titers (ng/ul). Detailed descriptions of the study cohorts, data collection and analysis can be found in: Fitzsimmons et al. 2012 DOI:10.1128/IAI.00641-12

Individual level S. haematobium infection data from three villages in the Segou Region, Mali. Data include human host age, sex and residence in high or moderate transmission intensity villages; pre-treatment baseline CAA measurement; 9-week post-treatment urine filtration S. haematobium egg counts (eggs/10 ml urine); 2-year post-treatment infection status (presence/absence of S. haematobium eggs by urine filtration); post-treatment seroprevalence of measurable IgE responses to specified members of the Tegument Allergen Like protein family (compared to non-endemic control response, data also available); pre-treatment IgE and IgG4 seroprevalence to specific ShTAL proteins; pre- and post-treatment IgE-TAL titers (ng/ul). Detailed descriptions of the study cohorts, data collection and analysis can be found in: Wilson et al. 2014 DOI: 10.1093/infdis/jiu374